1、Application of Recombinant Collagen in CosmeticsShengwei Fu,Ph.D.Jiangsu Trautec Medical Technology Co.,Ltd.1Established in 20152015Operate a 300,000-square-foot production facility in Jiangsu,China300,000Recombinant collagen core sequence patents7Company OverviewOn August 10,2022,Trauteccompleted i
2、ts first round of200 million RMB financing,ledby ShiseidoOn November 15,2022,TrautecandShiseidoChinabegancooperation in medical beautyIn 2023,Trautec completed200 million RMB series Bfundraise led by L CattertonPartnershipRecombinant collagen:rhCol IIIrhCol IAnti-ageing in dermisAnti-ageing in dermi
3、srhCol XVIIAnti-ageing in basement membraneAnti-hair lossLow molecular weight rhColBetter penetrationcapacityProducts overview rhCol IVAnti-ageing in basement membranerhCol VIIAnti-ageing in basement membranerhCol VIAnti-ageing in dermis&basement membranerhCol IIUnique typeWith a view to a sustainab
4、le future,Trautec is further investing in biosynthesis research and innovation.Our green biomanufacturing approach through cell factories improves productivity and also reduces greenhouse gas emissions.Trautec strives to explore science and technology to promote low carbon emission reduction and gre
5、en production.We are moving forward together towards a better future and ultimately achieving a sustainable social ecology.Trautec has successfully applied ISO14064 for enterprise,ISO14067 for product carbon footprint.Green,Sustainable,Environmental friendly Constructing a restructured futureNo Anim
6、al TestsMild and harmlessLow carbon emission reductionSustainble developmentAs a leading company in the synthetic biology,Trautec has successfully gained Bronze Medal byEcovadis certificate.We are dedicated to practising ESG principles,and moving toward a green,sustainable,and regenerative world.Sus